T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Louisiana-Pacific
LPX
$5.16B
| $187M | 0.04% |
10,804,868
-1,056,820
| -9% | -$18.6M |
|
|
SGI
427
Somnigroup International
SGI
$13.5B
| $187M | 0.04% |
13,548,136
+8,742,148
| +182% | +$129M |
|
428
Home BancShares
HOMB
$6.16B
| $187M | 0.04% |
9,462,815
+651,001
| +7% | +$13.6M |
|
429
CoStar Group
CSGP
$12.4B
| $187M | 0.04% |
8,558,370
-631,050
| -7% | -$12.5M |
|
430
Landstar System
LSTR
$6.2B
| $185M | 0.04% |
2,691,436
+158,818
| +6% | +$10.5M |
|
431
Capitol Federal Financial
CFFN
$1.09B
| $184M | 0.04% |
13,212,800
-469,900
| -3% | -$6.27M |
|
|
SIVB
432
DELISTED
SVB Financial Group
SIVB
| $184M | 0.04% |
1,936,261
+22,659
| +1% | +$2.32M |
|
433
TherapeuticsMD
TXMD
$24M
| $184M | 0.04% |
433,343
+14,815
| +4% | +$6.11M |
|
434
Jack in the Box
JACK
$359M
| $183M | 0.04% |
2,130,900
+1,129,040
| +113% | +$85.2M |
|
435
DTE Energy
DTE
$28.7B
| $182M | 0.04% |
2,155,275
+46,974
| +2% | +$3.63M |
|
|
PX
436
DELISTED
Praxair Inc
PX
| $181M | 0.04% |
1,612,649
+420,911
| +35% | +$47.7M |
|
|
PF
437
DELISTED
Pinnacle Foods, Inc.
PF
| $181M | 0.04% |
3,907,914
-14,700
| -0.4% | -$639K |
|
438
Molson Coors Class B
TAP
$7.72B
| $181M | 0.04% |
1,787,384
+149,106
| +9% | +$14.7M |
|
439
Micron Technology
MU
$1.04T
| $180M | 0.04% |
13,116,804
-2,389,434
| -15% | -$27.2M |
|
440
Minerals Technologies
MTX
$2.28B
| $177M | 0.04% |
3,116,882
-140,918
| -4% | -$8.18M |
|
441
TransUnion
TRU
$15.1B
| $177M | 0.04% |
5,279,299
+1,266,355
| +32% | +$38.9M |
|
|
PE
442
DELISTED
PARSLEY ENERGY INC
PE
| $176M | 0.04% |
6,496,912
+757,958
| +13% | +$18.8M |
|
443
Enovis
ENOV
$1.38B
| $174M | 0.04% |
3,818,815
-1,298,283
| -25% | -$63.4M |
|
444
Expeditors International
EXPD
$23.4B
| $173M | 0.04% |
3,518,640
-71,200
| -2% | -$3.46M |
|
445
Portland General Electric
POR
$5.72B
| $171M | 0.04% |
3,878,556
-30,151
| -0.8% | -$1.23M |
|
446
Novavax
NVAX
$1.3B
| $171M | 0.04% |
1,174,156
+2,212
| +0.2% | +$254K |
|
447
Harley-Davidson
HOG
$2.69B
| $169M | 0.04% |
3,728,039
-2,058,507
| -36% | -$94.8M |
|
|
SEM
448
DELISTED
Select Medical
SEM
| $168M | 0.04% |
28,739,405
+1,049,977
| +4% | +$6.96M |
|
449
Intuit
INTU
$90.4B
| $168M | 0.04% |
1,507,694
+588,750
| +64% | +$61.6M |
|
450
Prosperity Bancshares
PB
$8.9B
| $168M | 0.04% |
3,295,949
+342,489
| +12% | +$17.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.